Vasocor

Vasocor, Inc. was a medical device company based in Charleston, South Carolina, that specialized in non-invasive cardiovascular diagnostic technology. The company developed the Vasogram (also known as the Sensit system), a plethysmography-based device designed to measure arterial compliance and detect early-stage atherosclerosis. Backed by investors like Credit Suisse First Boston, Vasocor's technology was validated through extensive clinical trials, including the Vasogram Improvement Program (VIP). While the company is no longer an independent entity, its diagnostic assets were acquired and integrated into the product portfolio of InterCare DX, Inc.